[Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer]

Tumori. 1969 Sep-Oct;55(5):277-89. doi: 10.1177/030089166905500504.
[Article in Italian]
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Digestive System / drug effects
  • Drug Synergism*
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Fluorouracil / therapeutic use*
  • Humans
  • Hydrazines / therapeutic use
  • Injections, Intravenous
  • Leukopenia / chemically induced
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / drug therapy*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Radiography

Substances

  • Antineoplastic Agents
  • Hydrazines
  • Fluorouracil